| Framework for Patient Engagement in Clinical Trials | 2023-05-24 | 15:00 – 16:00 hr | Virginie Hivert and María Cavaller Bellaubi | | |
| Introduction on Patient-Reported Outcomes and considerations before including them in a clinical trial. Study case from the ERN-EuroBloodNet | 2023-05-10 | 12:30 – 13:30 hr | Céline Desvignes-Gleizes, Andreas Glenthøj and Dore Peereboom | | |
| Designing and conducting clinical trials in rare diseases – what industries expect for partnering with clinical sites | 2023-04-14 | 12:30 – 13:30 hr | Diego Ardigò | | |
| Definition of orphan drug by the EMA | 2023-03-28 | 12:30 – 13:30 hr | Armando Magrelli | | |
| Essential requirements before thinking about a clinical trial | 2023-02-28 | 12:00 – 13:00 hr | Viviana Giannuzzi | | |
| WP5 Educational Webinar 2 “Practical guide on how to use the Catalogue of services and the IMT” | 2022-10-24 | 13:00 – 14:00 hr | Anton Ussi, Agustin Arasanz Duque and Rosan Vegter | | |
| Composite endpoints including patient relevant endpoints (Quality of Life) | 2022-05-06 | 16:00 – 18:30 hr | Johan Verbeeck | | |
| EMA Virtual meeting Repurposing ‘WALK-IN’ CLINIC | 2022-02-17 | 17:00 – 18:30 hr | | | |
| Does Randomization matter in RD clinical trials? | 2021-12-14 | | Ralf-Dieter Hilgers | | |
| EMA Webinar for SMEs and Academia on the Clinical Trials Regulation and the Clinical Trials Information System | 2021-11-29 | 9:00 – 13:30 hr | | | |
| Educational Webinar 1 Current research services available for the rare diseases community | 2021-11-08 | 15:00 – 16:00 hr | Anton Ussi | | |